| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 410.631 | 596.396 | 703.716 | 591.324 | 472.469 | 588.756 | 645.365 | 302.615 |
| Total Income - EUR | - | - | 412.289 | 596.396 | 704.873 | 595.924 | 472.465 | 588.756 | 645.365 | 303.538 |
| Total Expenses - EUR | - | - | 389.391 | 596.392 | 648.870 | 553.720 | 425.192 | 474.117 | 555.341 | 289.348 |
| Gross Profit/Loss - EUR | - | - | 22.898 | 4 | 56.002 | 42.204 | 47.273 | 114.639 | 90.024 | 14.191 |
| Net Profit/Loss - EUR | - | - | 18.736 | -5.984 | 48.830 | 36.463 | 43.115 | 109.635 | 82.921 | 11.364 |
| Employees | - | - | 0 | 7 | 5 | 3 | 5 | 5 | 6 | 4 |
Check the financial reports for the company - Anamir Biomarket Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 1.745 | 305 | 233 | 15.380 | 11.474 | 7.572 |
| Current Assets | - | - | 86.742 | 74.122 | 152.437 | 169.278 | 230.535 | 322.873 | 401.150 | 419.964 |
| Inventories | - | - | 36.942 | 28.280 | 57.445 | 151.944 | 217.987 | 315.483 | 391.078 | 406.289 |
| Receivables | - | - | 46.280 | 7.351 | 90.481 | 11.810 | 6.722 | 4.145 | 4.367 | 9.682 |
| Cash | - | - | 3.520 | 38.491 | 4.511 | 5.524 | 5.825 | 3.245 | 5.706 | 3.993 |
| Shareholders Funds | - | - | 18.780 | 12.452 | 61.040 | 96.346 | 137.325 | 247.385 | 329.556 | 339.078 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 67.962 | 61.671 | 93.177 | 73.272 | 93.444 | 90.867 | 83.068 | 88.458 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Anamir Biomarket Srl